Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RANKL Inhibition and Breast Tissue Biomarkers in Premenopausal Women With Dense Breasts

NCT03629717 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03629717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03629717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RANKL Inhibition and Breast Tissue Biomarkers in Premenopausal Women With Dense Breasts
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2018
Completion date
December 3, 2018
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer prevention, mammographic density